AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16148997 — intervention group
Group type: COMPARATOR
Intervention: Single cancer group (SCG)
Number of subjects: 1125
Study 11822980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 0
Study 11822980 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytoestrogens and selective estrogen receptor modulators
Number of subjects: 0
Study 9442338 — intervention group
Group type: COMPARATOR
Intervention: (-)-3PPP, 300 mg B.I.D. in early efficacy study
Number of subjects: 19
Study 9442338 — intervention group
Group type: EXPERIMENTAL
Intervention: (-)-3PPP in both studies
Number of subjects: 19
Study 7557275 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS 201-995
Number of subjects: 19
Study 7557275 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide
Number of subjects: 19
Study 7557275 — intervention group
Group type: COMPARATOR
Intervention: Control group (50 patients)
Number of subjects: 19
Study 2643894 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol, 0.075 mg/kg
Number of subjects: 150
Study 2643894 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine, 1.5 mg/kg
Number of subjects: 150
Study 2643894 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lidocaine, 1.5 mg/kg and droperidol, 0.025 mg/kg
Number of subjects: 150
Study 128907 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse protocol group
Number of subjects: 419
Study 128907 — intervention group
Group type: COMPARATOR
Intervention: Control group (managed by physicians)
Number of subjects: 419
Study 29949407 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary sodium (300 mmol/day, 7 days)
Number of subjects: 14
Study 29949407 — intervention group
Group type: COMPARATOR
Intervention: Low dietary sodium (20 mmol/day, 7 days)
Number of subjects: 14
Study 29949407 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute intravenous hypertonic saline infusion (HSI)
Number of subjects: 14
Study 27060853 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline/Olanzapine combination treatment
Number of subjects: 87
Study 25504098 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral percutaneous kyphoplasty (PKP)
Number of subjects: 316
Study 25504098 — intervention group
Group type: COMPARATOR
Intervention: Bilateral percutaneous kyphoplasty (PKP)
Number of subjects: 316
Study 23363721 — intervention group
Group type: EXPERIMENTAL
Intervention: Domestic hydrochloric trimetazidine capsules
Number of subjects: 24
Study 23363721 — intervention group
Group type: COMPARATOR
Intervention: Imported hydrochloric trimetazidine tablets
Number of subjects: 24
Study 20051219 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 20 Hz rTMS of the right DLPFC
Number of subjects: 30
Study 20051219 — intervention group
Group type: EXPERIMENTAL
Intervention: Active 20 Hz rTMS of the left DLPFC
Number of subjects: 30
Study 20051219 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 30
Study 18310598 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual feedback on performance
Number of subjects: 130
Study 18310598 — intervention group
Group type: COMPARATOR
Intervention: Group feedback
Number of subjects: 130
Study 15841592 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% carbohydrate drink (low concentration)
Number of subjects: 8
Study 15841592 — intervention group
Group type: EXPERIMENTAL
Intervention: 11% carbohydrate drink (high concentration)
Number of subjects: 8
Study 12218773 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 dollars cash incentive
Number of subjects: 1200
Study 12218773 — intervention group
Group type: COMPARATOR
Intervention: 5 dollars cash incentive
Number of subjects: 1200
Study 12218773 — intervention group
Group type: EXPERIMENTAL
Intervention: Mint candy included
Number of subjects: 1200
Study 12218773 — intervention group
Group type: EXPERIMENTAL
Intervention: Large envelope used
Number of subjects: 1200
Study 9802745 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP‐1 (1.2 pmol x kg(‐1) x min(‐1))
Number of subjects: 10
Study 9802745 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl with 1% human serum albumin)
Number of subjects: 10
Study 8002198 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey questionnaire utilizing a 30-day recall period with the combination of cough, fast breathing or shortness of breath, and fever.
Number of subjects: 0
Study 8002198 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey questionnaire with a 15-day recall period.
Number of subjects: 0
Study 8002198 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey questionnaire with a 30-day recall period.
Number of subjects: 0
Study 8002198 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey questionnaire in a trained population under surveillance.
Number of subjects: 0
Study 2524749 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid (Surgam)
Number of subjects: 60
Study 2524749 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30033645 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginger root supplement (60 mg of active gingerols/day, four capsules)
Number of subjects: 300
Study 30033645 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 28832589 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal counseling program focused on nuisance bleedings
Number of subjects: 448
Study 28832589 — intervention group
Group type: COMPARATOR
Intervention: Usual discharge process (control arm)
Number of subjects: 448
Study 25801058 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg alone
Number of subjects: 0
Study 25801058 — intervention group
Group type: EXPERIMENTAL
Intervention: Tong Xin Luo + Simvastatin 20 mg (after 7 days of TCM)
Number of subjects: 0
Study 25801058 — intervention group
Group type: EXPERIMENTAL
Intervention: Nao Xin Tong + Simvastatin 20 mg (after 7 days of TCM)
Number of subjects: 0
Study 25801058 — intervention group
Group type: EXPERIMENTAL
Intervention: Guan Mai Ning + Simvastatin 20 mg (after 7 days of TCM)
Number of subjects: 0
Study 25801058 — intervention group
Group type: EXPERIMENTAL
Intervention: Yin Xing Ye + Simvastatin 20 mg (after 7 days of TCM)
Number of subjects: 0
Study 23969508 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline for occupational physicians (OPs)
Number of subjects: 524
Study 23969508 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 524
Study 21838852 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose citalopram
Number of subjects: 0
Study 19145455 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol intake (3.3 g/day)
Number of subjects: 22
Study 19145455 — intervention group
Group type: COMPARATOR
Intervention: Typical American diet
Number of subjects: 22
Study 19145455 — intervention group
Group type: COMPARATOR
Intervention: Step 1 diet
Number of subjects: 22
Study 17925563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (60 mg/m2) plus gemcitabine (1,000 mg/m2)
Number of subjects: 159
Study 17925563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (40 mg/m2) plus vinorelbine (25 mg/m2)
Number of subjects: 159
Study 14963675 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg cerivastatin
Number of subjects: 15
Study 11712610 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation
Number of subjects: 15
Study 11712610 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic intervention measures
Number of subjects: 15
Study 11712610 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercises
Number of subjects: 15
Study 11712610 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manipulation combined with soft tissue therapy
Number of subjects: 15
Study 11712610 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral therapy
Number of subjects: 15
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: HSM IOL (group I)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable acrylic IOL (group II)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable three-piece silicone (group III)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Foldable single-piece silicone (group IV)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: PMMA group (part of group I)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone monobloc group (part of group IV)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic group (part of group II)
Number of subjects: 157
Study 9759415 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone three-piece group (part of group III)
Number of subjects: 157
Study 7822584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue exposure with smoking cues during deprivation (12 hr)
Number of subjects: 0
Study 7822584 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue exposure with smoking cues during non-deprivation
Number of subjects: 0
Study 7822584 — intervention group
Group type: COMPARATOR
Intervention: Control cues during deprivation
Number of subjects: 0
Study 7822584 — intervention group
Group type: COMPARATOR
Intervention: Control cues during non-deprivation
Number of subjects: 0
Study 30213365 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg morphine added to PMDI (Group A)
Number of subjects: 97
Study 30213365 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg morphine added to spinal anesthesia (Group B)
Number of subjects: 97
Study 30213365 — intervention group
Group type: COMPARATOR
Intervention: No morphine added (Group C)
Number of subjects: 97
Study 27481311 — intervention group
Group type: EXPERIMENTAL
Intervention: GI PROMIS measures
Number of subjects: 371
Study 27481311 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 371
Study 24444113 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific reminders shown to healthcare professionals (HCP) in the intervention group.
Number of subjects: 13588
Study 24444113 — intervention group
Group type: COMPARATOR
Intervention: Control group with no reminders shown to HCP.
Number of subjects: 13588
Study 24444113 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific reminders shown to HCP in the intervention group (follow-up over 6 months).
Number of subjects: 13588
Study 24444113 — intervention group
Group type: COMPARATOR
Intervention: Control group with no reminders shown to HCP (follow-up over 6 months).
Number of subjects: 13588
Study 21277694 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to protocol specified radiation therapy guidelines (PP)
Number of subjects: 416
Study 21277694 — intervention group
Group type: COMPARATOR
Intervention: Non-adherence to protocol specified radiation therapy guidelines (<PP)
Number of subjects: 416
Study 21277694 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine treatment
Number of subjects: 416
Study 21277694 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine treatment with adherence to RT guidelines (PP)
Number of subjects: 416
Study 20135601 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning software training for 4-6 hours
Number of subjects: 20
Study 20135601 — intervention group
Group type: COMPARATOR
Intervention: Conventional learning material
Number of subjects: 20
Study 18307372 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem administration in healthy volunteers
Number of subjects: 0
Study 18307372 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipenem administration in critical care patients
Number of subjects: 0
Study 16575033 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (Group R) - basal infusion of 0.02-0.04 microg x kg(‐1) x min(‐1) with self-administered bolus doses of 0.3 microg x kg(‐1) i.v. every minute as required.
Number of subjects: 40
Study 16575033 — intervention group
Group type: COMPARATOR
Intervention: Propofol (Group P) - initial plasma target concentration set at 3-4 microg x mL(‐1).
Number of subjects: 40
Study 16575033 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Remifentanil and Propofol)
Number of subjects: 40
Study 12679757 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral glycoprotein IIb/IIIa antagonist orbofiban plus aspirin
Number of subjects: 10281
Study 12679757 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 10281
Study 11294060 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (300 mg daily)
Number of subjects: 5
Study 11294060 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride (400 to 800 mg/day, up to 1,200 mg/day)
Number of subjects: 5
Study 11294060 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 5
Study 8923094 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 217
Study 8923094 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine
Number of subjects: 217
Study 1525816 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative Coronary Angiography (QCA)
Number of subjects: 50
Study 1525816 — intervention group
Group type: COMPARATOR
Intervention: Caliper measurements
Number of subjects: 50
Study 1525816 — intervention group
Group type: COMPARATOR
Intervention: Visual analysis by independent observers
Number of subjects: 50
Study 2866133 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 40 mg at bedtime
Number of subjects: 224
Study 2866133 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 20 mg b.i.d.
Number of subjects: 224
Study 2866133 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 40 mg b.i.d.
Number of subjects: 224
Study 2866133 — intervention group
Group type: COMPARATOR
Intervention: ranitidine 150 mg b.i.d.
Number of subjects: 224
Study 31761855 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-month education training program for care staff
Number of subjects: 119
Study 31761855 — intervention group
Group type: COMPARATOR
Intervention: Usual care for care staff
Number of subjects: 119
Study 29991270 — intervention group
Group type: EXPERIMENTAL
Intervention: Diacutaneous fibrolysis
Number of subjects: 52
Study 29991270 — intervention group
Group type: COMPARATOR
Intervention: Sham diacutaneous fibrolysis
Number of subjects: 52
Study 26489989 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer unlocked closure technique
Number of subjects: 76
Study 26489989 — intervention group
Group type: COMPARATOR
Intervention: Single-layer technique
Number of subjects: 76
Study 25378974 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg pitavastatin
Number of subjects: 0
Study 25378974 — intervention group
Group type: COMPARATOR
Intervention: 10 mg pravastatin
Number of subjects: 0
Study 22722481 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative administration of tegafur suppositories (group A)
Number of subjects: 0
Study 22722481 — intervention group
Group type: COMPARATOR
Intervention: No preoperative treatment (group B)
Number of subjects: 0
Study 20706077 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted approach
Number of subjects: 29
Study 20706077 — intervention group
Group type: COMPARATOR
Intervention: Straight laparoscopic approach
Number of subjects: 29
Study 17590291 — intervention group
Group type: COMPARATOR
Intervention: Black cohosh alone (monotherapy)
Number of subjects: 6141
Study 17590291 — intervention group
Group type: EXPERIMENTAL
Intervention: Black cohosh in combination with St. John's wort (combination therapy)
Number of subjects: 6141
Study 17590291 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies (Black cohosh alone and combination therapy)
Number of subjects: 6141
Study 16305289 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once/day
Number of subjects: 196
Study 16305289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 12045767 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (RMGI) adhesive
Number of subjects: 61
Study 12045767 — intervention group
Group type: COMPARATOR
Intervention: Resin-based adhesive (control)
Number of subjects: 61
Study 9776558 — intervention group
Group type: EXPERIMENTAL
Intervention: Urografin 76% (sodium‐meglumine diatrizoate)
Number of subjects: 15
Study 9776558 — intervention group
Group type: EXPERIMENTAL
Intervention: Telebrix 38 (sodium‐meglumine ioxythalamate)
Number of subjects: 15
Study 9776558 — intervention group
Group type: COMPARATOR
Intervention: No contrast materials (control group)
Number of subjects: 15
Study 8527271 — intervention group
Group type: EXPERIMENTAL
Intervention: 12.5 mg oral ketoprofen
Number of subjects: 24
Study 8527271 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg oral ketoprofen
Number of subjects: 24
Study 8527271 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral ketoprofen
Number of subjects: 24
Study 8527271 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg i.v. ketoprofen
Number of subjects: 24
Study 8527271 — intervention group
Group type: EXPERIMENTAL
Intervention: R-ketoprofen (oral administration)
Number of subjects: 24
Study 1699508 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% sodium chloride
Number of subjects: 106
Study 1699508 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% sodium chloride per 6% dextran 70
Number of subjects: 106
Study 1699508 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's (control)
Number of subjects: 106
Study 526380 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane
Number of subjects: 105
Study 526380 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 105
Study 31264282 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra-fine particle hydrofluoroalkane beclomethasone dipropionate (mean dose 355µg) after switching from fine particle ICS (mean dose 710µg)
Number of subjects: 24
Study 31264282 — intervention group
Group type: COMPARATOR
Intervention: Control group (fine particle ICS)
Number of subjects: 24
Study 27868321 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan 97/103 mg b.i.d.
Number of subjects: 8399
Study 27868321 — intervention group
Group type: COMPARATOR
Intervention: enalapril 10 mg b.i.d.
Number of subjects: 8399
Study 25751116 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 101
Study 25751116 — intervention group
Group type: COMPARATOR
Intervention: Community Treatment by Experts
Number of subjects: 101
Study 25751116 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Treatments
Number of subjects: 101
Study 23865840 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring (CGM)
Number of subjects: 25
Study 23865840 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring blood glucose
Number of subjects: 25
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized NIMV (S‐NIMV) at 20/min
Number of subjects: 16
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized NIMV (S‐NIMV) at 40/min
Number of subjects: 16
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: NIMV at 20/min
Number of subjects: 16
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: NIMV at 40/min
Number of subjects: 16
Study 20924313 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 16
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: NIMV
Number of subjects: 16
Study 20924313 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐NIMV
Number of subjects: 16
Study 19996727 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 21
Study 19996727 — intervention group
Group type: COMPARATOR
Intervention: Befriending (BF)
Number of subjects: 21
Study 16700870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxonidine
Number of subjects: 0
Study 16700870 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 0
Study 12764905 — intervention group
Group type: EXPERIMENTAL
Intervention: Shengfu Injection (SFI) plus chemotherapy
Number of subjects: 61
Study 11054326 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide sustained drug delivery device
Number of subjects: 5
Study 12206030 — intervention group
Group type: EXPERIMENTAL
Intervention: Colgate Optimized Stannous Fluoride (COSF) dentifrice, containing 0.454% stannous fluoride, stannous chloride, polyphosphate, and citrate in a silica base, used twice daily for 6 months.
Number of subjects: 0
Study 12206030 — intervention group
Group type: COMPARATOR
Intervention: Control dentifrice group
Number of subjects: 0
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microliters drop of phenylephrine
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 microliters drop of phenylephrine
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid closure with 10 microliters drop
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid closure with 30 microliters drop
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid closure and 10 microliters drop size
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyelid closure and 30 microliters drop size
Number of subjects: 13
Study 8442496 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microliters drop followed by eyelid closure
Number of subjects: 13
Study 3722507 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% topical minoxidil
Number of subjects: 89
Study 3722507 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% topical minoxidil
Number of subjects: 89
Study 3722507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 3722507 — intervention group
Group type: COMPARATOR
Intervention: 0.01% topical minoxidil
Number of subjects: 89
Study 3722507 — intervention group
Group type: COMPARATOR
Intervention: 0.1% topical minoxidil
Number of subjects: 89
Study 31511069 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (anti-PD-L1 antibody) treatment
Number of subjects: 14
Study 27220057 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-facilitated cognitive-behavioral bibliotherapy (n = 31)
Number of subjects: 62
Study 27220057 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (n = 31)
Number of subjects: 62
Study 25909982 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 427